Geel, B.N. van

cancer breast breast cancer patient women brca 1 mutation prophylactic mastectomy study brca 2 mutation mastectomy survival chemotherapy prophylactic group carrier table family metastatic fi rst-line chemotherapy therapy disease tumor breast cancer patients brca 1- adjuvant surveillance metastatic breast cancer 2-associated treatment 1-associated metastatic disease seynaeve c result metastase response support difference percent signi follow-up oncology brca 1-associated patients status signi ficantly seynaeve society diagnosis brekelman surgery surveillance group incidence consultation history 1/2 characteristic post-relapse survival brca 2-mutation carriers oncology information downloaded brca 2 mutations bc patients analysis interval erasmu psychologist receptor number progression-free breast cancer res brca 2-associated patients oncol rst-line information fi rst progression-free survival american society month ficantly copyright 2001 massachusetts brca 2-associated